Even Hardcore Smokers May Quit If Given Right Tools, Study Finds
By Dennis Thompson HealthDay Reporter
TUESDAY, Oct. 22, 2024 -- Smokers find it easier to quit if they’re automatically offered support, even if they didn't ask for it, a new clinical trial finds.
Quit rates were higher among health system patients placed in an “opt-out” program, in which tobacco cessation medications and counseling are automatically prescribed upon learning they smoke, researchers found.
It’s called an “opt-out” program because people get the meds and counseling unless they opt out of it.
After a month, 22% of people in an opt-out group had quit smoking, compared with only 16% of smokers who had to opt into the cessation program, researchers reported recently in the journal JAMA Network Open.
“Health care providers don’t ask patients if they would like to get evidence-based care for other conditions like asthma, high blood pressure or diabetes,” said senior researcher Kimber Richter, a professor of population health with the University of Kansas Cancer Center. “They just identify a health condition and provide the best care possible.”
“For no reason, we’ve always treated tobacco dependence differently -- we wanted to see what would happen if we proactively treated tobacco dependence,” Richter added in a university news release.
For the clinical trial, nearly 750 smokers receiving medical care from the University of Kansas Health System were asked about their desire to quit, and then randomly placed into one of two groups.
Those assigned to the opt-out group automatically received a starter kit of nicotine patches and gum, a prescription for quit smoking medication, a treatment plan and follow-up calls.
Folks in the opt-out group were free to decline any of these components, but they had to actively decline the offer.
People in the opt-in group were asked whether they’d like any or all of these quit-smoking supports, and only got the components they wanted.
In both groups, people were more likely to successfully quit if they wanted to stop smoking in the first place.
But whether they wanted to quit or not, smokers were more likely to stop if they were automatically provided support rather than having to ask for it, results showed.
For example, opt-out assistance led to successful quitting in about 8% of smokers with absolutely no desire to quit, researchers found. In contrast, 32% of those with a strong desire to stop smoking quit after being plopped into an opt-out program.
Also, the increased benefit from opt-out treatment was the same for all smokers, regardless of their desire to quit, researchers found.
"This study is significant because it shows that proactively providing help without requiring a strong initial desire to quit can still make a big difference," said lead researcher Byron Gajewski, a professor of biostatistics and data science at the University of Kansas Cancer Center. "It suggests that opt-out treatment could be an effective strategy to help more people quit smoking."
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-23 06:00
Read more
- CagriSema Demonstrates Superior Weight Loss in Adults with Obesity or Overweight in the REDEFINE 1 Trial
- Biomarkers of Insulin Resistance Are Risk Factors for Aortic Stenosis
- Concerns Raised as Too Few U.S. Children Have Received Flu Vaccine
- FDA Elevates Costco Egg Recall to Class 1 Over Salmonella Risk
- Syros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome with RARA Gene Overexpression
- Specific Pesticides Linked to Increased Risk for Rheumatoid Arthritis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions